Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Oncoimmunology|December 5, 2018
Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinomaKenzo Ohara, Takayuki Ohkuri, Takumi Kumai, et al.
Oncoimmunology|July 30, 2016
Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapyKei Ishibashi, Takumi Kumai, Takayuki Ohkuri, et al.
Blood|October 11, 2011
Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal typeRitsuro Suzuki, Motoko Yamaguchi, Koji Izutsu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 22, 2019
Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphomaToshihiro Nagato, Seigo Ueda, Miki Takahara, et al.
Oncoimmunology|January 10, 2022
Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinomaMichihisa Kono, Hiroki Komatsuda, Hidekiyo Yamaki, et al.
Modern Rheumatology|May 12, 2016
Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in JapanYasuaki Harabuchi, Kan Kishibe, Kaori Tateyama, et al.
Oncology Reports|January 12, 2005
p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK/T-cell lymphoma in Korea and JapanTadashi Hongyo, Yoshihiko Hoshida, Shin-Ichi Nakatsuka, et al.
Cancer Immunology, Immunotherapy : CII|February 23, 2020
Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancerMizuho Ohara, Kenzo Ohara, Takumi Kumai, et al.
Modern Rheumatology|December 17, 2021
Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare DatabaseKenji Nagasaka, Shinya Kaname, Koichi Amano, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2021
Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machineryMichihisa Kono, Takumi Kumai, Ryusuke Hayashi, et al.
Pageof 16